179 related articles for article (PubMed ID: 36116788)
1. Coincident Regulation of PLC
Sanchez GA; Jutkiewicz EM; Ingram S; Smrcka AV
Mol Pharmacol; 2022 Dec; 102(6):269-279. PubMed ID: 36116788
[TBL] [Abstract][Full Text] [Related]
2. Mice Expressing Regulators of G protein Signaling-insensitive Gαo Define Roles of
Bouchet CA; McPherson KB; Li MH; Traynor JR; Ingram SL
Mol Pharmacol; 2021 Sep; 100(3):217-223. PubMed ID: 34135098
[TBL] [Abstract][Full Text] [Related]
3. Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced nociception in a Tolerant State.
Sanchez GA; Smrcka AV; Jutkiewicz EM
Mol Pharmacol; 2024 May; ():. PubMed ID: 38769020
[TBL] [Abstract][Full Text] [Related]
4. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
5. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane localization of the μ-opioid receptor controls spatiotemporal signaling.
Halls ML; Yeatman HR; Nowell CJ; Thompson GL; Gondin AB; Civciristov S; Bunnett NW; Lambert NA; Poole DP; Canals M
Sci Signal; 2016 Feb; 9(414):ra16. PubMed ID: 26861044
[TBL] [Abstract][Full Text] [Related]
7. [Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse].
Narita M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Jun; 23(3):121-8. PubMed ID: 12884752
[TBL] [Abstract][Full Text] [Related]
8. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.
Marker CL; Luján R; Loh HH; Wickman K
J Neurosci; 2005 Apr; 25(14):3551-9. PubMed ID: 15814785
[TBL] [Abstract][Full Text] [Related]
9. A novel Gbetagamma-subunit inhibitor selectively modulates mu-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence.
Mathews JL; Smrcka AV; Bidlack JM
J Neurosci; 2008 Nov; 28(47):12183-9. PubMed ID: 19020012
[TBL] [Abstract][Full Text] [Related]
10. Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids.
Xie W; Samoriski GM; McLaughlin JP; Romoser VA; Smrcka A; Hinkle PM; Bidlack JM; Gross RA; Jiang H; Wu D
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10385-90. PubMed ID: 10468617
[TBL] [Abstract][Full Text] [Related]
11. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.
Bagley EE; Chieng BC; Christie MJ; Connor M
Br J Pharmacol; 2005 Sep; 146(1):68-76. PubMed ID: 15980868
[TBL] [Abstract][Full Text] [Related]
12. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
13. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
[TBL] [Abstract][Full Text] [Related]
15. Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner.
Santhappan R; Crowder AT; Gouty S; Cox BM; Côté TE
J Neurochem; 2015 Oct; 135(1):76-87. PubMed ID: 26119705
[TBL] [Abstract][Full Text] [Related]
16. Relationship between receptor occupancy and the antinociceptive effect of mu opioid receptor agonists in male rats.
Takai N; Miyajima N; Tonomura M; Abe K
Brain Res; 2018 Feb; 1680():105-109. PubMed ID: 29269051
[TBL] [Abstract][Full Text] [Related]
17. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
[TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
19. Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.
Chu J; Zheng H; Zhang Y; Loh HH; Law PY
Cell Signal; 2010 Apr; 22(4):684-96. PubMed ID: 20043990
[TBL] [Abstract][Full Text] [Related]
20. Homologous Regulation of Mu Opioid Receptor Recycling by G
Kunselman JM; Zajac AS; Weinberg ZY; Puthenveedu MA
Mol Pharmacol; 2019 Dec; 96(6):702-710. PubMed ID: 31575621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
